Novartis | DEBITO

Prezzo Delle Azioni
156.42
Cambio Giornaliero
2.62 1.70%
Mensile
10.22%
Annuale
47.28%
Q1 Previsione
152.60




DEBITO Cambiamento Data
AbbVie USD 1000K 70.48B 2025-09
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.84B 1.19B 2025-06
Bausch Health Companies USD 21.74B 228M 2025-06
Biogen USD 6.29B 1.7M 2025-12
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Canopy Growth CAD 259.33M 68.47M 2025-09
Corcept Therapeutics USD 6.6M 2.03M 2025-06
Drreddys Laboratories INR 67.73B 19.09B 2025-12
Eli Lilly USD 42.51B 2.6B 2025-09
Gilead Sciences USD 24.95B 6M 2025-06
GlaxoSmithKline GBP 17.75B 396M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
J&J USD 45.8B 4.97B 2025-09
Merck USD 41.37B 5.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Novartis USD 32.02B 615M 2025-09
Pacira USD 376.72M 203.77M 2025-09
Perrigo USD 3.65B 454.7M 2025-06
Pfizer USD 60.85B 78M 2025-09
Prestige Brands USD 1.04B 1.7M 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 21.76B 530M 2025-09
Sanofi EUR 21.76B 530M 2025-09
Supernus Pharmaceuticals USD 31.77M 531K 2025-06
Zoetis USD 6.79B 1.11B 2025-06


Novartis DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.